Policy Publications


Global Initiative for Drug Policy Reform 

Illicit Drug Markets and Dimensions of Violence in Guatemala (2013)
Amanda Feilding, Project Director

This Report looks at socio-economic indicators while exploring Guatemala’s illicit drugs market. It makes evidence-informed policy recommendations based on the Beckley Foundation Latin American Chapter‘s original research. The Beckley Foundation Latin American Chapter outlined reform and public engagement tactics that we hope will lead to public-health minded alternative approaches to the War on Drugs.

Licensing and Regulation of the Cannabis Market in England and Wales: Towards a Cost/Benefit Analysis (2013)
Stephen Pudney, Emilia Del Bono, Mark Bryan

The Beckley Foundation, the leading global advocate for scientifically-based drug policy reform, released this important report that quantifies for the first time, the potential revenues to be gained from legal regulation and taxation of the cannabis market in England and Wales. The study, carried out by the Institute for Social and Economic Research at the University of Essex UK and led by Professor Stephen Pudney, suggests the most plausible net benefit is around £300m as well as a £0.5-1.25bn reduction of the government deficit through taxation.

Paths for Reform: Proposed Options for Alternative Drug Policies in Guatemala (2013)
Amanda Feilding, Project Director; Corina Giacomello, Field Researcher

These initial drug policy proposals, produced at the invitation of President Otto Pérez Molina, were presented to the President and his key advisors in January 2013. They were received enthusiastically, and President Pérez Molina has since announced his intention at Davos and other international fora to adopting several of the recommendations, including using the opium poppy crop to provide pain-relieving medications for the Guatemalan people and decriminalising minor drug related crimes. The proposals also influenced the Declaration of the OAS General Assembly in June 2013.

Roadmaps to Reforming the UN Drug Conventions (2012)
Edited by Robin Room; Contributions by Robin Room and Sarah Mackay

This report maps out how the Conventions can be amended in order to give countries greater freedom to adopt drug policies better suited to their individual needs. In particular, the report details the treaty amendments that would be necessary if a country (or a group of countries) wished to experiment with either i) explicit decriminalisation or ii) a regulated market in one or more controlled substances.

Rethinking US Drug Policy (2011)
Peter Hakim

This project, carried out in collaboration with ‘The Dialogue’ calls for a serious and far-reaching national debate on the costs of current US drug policies and a search for alternative strategies. Its data analysis was cited in the 2012 US Senate Caucus for Narcotics Control report- ‘Reducing the US Demand for Illicit Drugs’.

Cannabis Policy: Moving Beyond Stalemate Global Cannabis Commission Report (2008)
Robin Room, Benedikt Fischer, Wayne Hall, Simon Lenton, Peter Reuter

Despite cannabis being the most widely used illegal drug, and therefore the mainstay of the War on Drugs, it has only ever held a relatively marginal position in international drug policy discussions. In recognition of this, Amanda convened a team of the world’s leading drug policy analysts to prepare this report as an overview of the latest scientific evidence surrounding cannabis and the policies that control its use.



Drug Policy Programme: Reports and Briefing Papers (2004-2008)

These Reports and briefing papers were conceived as part of the The Beckley Foundation Drug Policy Programme (BFDPP), an initiative dedicated to providing a rigorous, independent review of the effectiveness of national and international drug policies. The aim of this programme of research and analysis was to assemble and disseminate material that supported the rational consideration of complex drug policy issues, hopefully leading to a more effective management of the widespread use of psychoactive substances. Although these Reports are now a few years old, much of the information and analysis they contain remains as pertinent now as it was when they were originally published.

Report 1. Towards a Review of Global Policies on Illegal Drugs
Marcus Roberts, Axel Klein, Mike Trace, May 2004.

Report 2. Assessing Drug Policy: Principles & Practice
Marcus Roberts, Axel Klein, Mike Trace.

Report 3. Law Enforcement and Supply Reduction
Marcus Roberts, Axel Klein, Mike Trace.

Report 4. Reducing Drug Related Harms to Health: A Review of the Global Evidence
Neil Hunt, Mike Trace, Dave Bewley-Taylor.

Report 5. Reducing Drug Related Crime: An Overview of the Global Evidence
Alex Stevens, Mike Trace, Dave Bewley-Taylor.

Report 6. Facing the future: The Challenge For National and International Drug Policy
Marcus Roberts, Dave Bewley-Taylor, Mike Trace.

Report 7. The International Narcotics Control Board: Watchdog or Guardian of the UN 
Drug Control Conventions?
Dave Bewley-Taylor, Mike Trace

Report 8. Cannabis and Mental Health Responses to the Emerging Evidence
Neil Hunt, Simon Lenton, John Witton

Report 9. Monitoring Drug Policy Outcomes: The measurement of drug related harm
Marcus Roberts, Dave Bewley-Taylor, Mike Trace

Report 10. Treatment for Dependent Drug Use: A guide for policymakers
Alex Stevens, Christopher Hallam, Mike Trace

Report 11. The funding of the United Nations Office on Drugs and Crime; an unfinished 
Dave Bewley-Taylor, Mike Trace

Report 12. Prisons & Drugs: a global review of incarceration, drug use and drug 
Kate Dolan, Effat Merghati Khoei, Cinzia Brentari, Alex Stevens

Report 13. Recalibrating the Regime: The need for a human rights-based approach to 
international drug policy
insert names here

Report 14. Understanding Drug Markets And How To Influence Them
Laura Wilson, Alex Stevens

Report 15. Drug Markets and Urban Violence: Can tackling one reduce the other?

Report 16. The Incarceration of Drug Offenders: An Overview
Dave Bewley-Taylor, Chris Hallam, Rob Allen

Briefing Papers

Number 1. Reclassification of Cannabis in the United Kingdom
Mike Trace, Axel Klein, Marcus Roberts, May 2004.

Number 2. Drug Policy and the HIV Pandemic in Russia and Ukraine
Axel Klein, Marcus Roberts, Mike Trace, May 2004.

Number 3. Drug Consumption Rooms
Marcus Roberts, Axel Klein, Mike Trace.

Number 4. Upheavals in the Australian Drug Market: Heroin Drought, Stimulant Flood
William Bush, Marcus Roberts, Mike Trace.

Number 5. Thailand’s ‘War on Drugs’
Marcus Roberts, Mike Trace, Axel Klein.

Number 6. Decriminalisation of Drugs in Portugal: A Current Overview
Laurence Allen, Mike Trace, Axel Klein.

Number 7. Incarceration of Drug Offenders: Costs and Impacts
Dave Bewley-Taylor, Mike Trace, Alex Stevens, June 2005.

Number 8. The Rise Of Harm Reduction in the Islamic Republic of Iran
Bijan Nissaramanesh, Mike Trace, Marcus Roberts, July 2005.

Number 9. UNAIDS & The Prevention of HIV Infection Through Injecting Drug Use
Mike Trace, Diane Riley, Gerry Stimson, September 2005.

Number 10. Drug Policy in India: Compounding Harm?
Molly Charles, Dave Bewley-Taylor, Amanda Feilding, October 2005.

Number 11. Report of the Third Beckley International Drug Policy Seminar
Mike Trace, Gábor Somogyi, Christopher Hallam, Dave Bewley-Taylor, January 2007.

Number 12. The Australian “Heroin Shortage” Six Years On: What, if any, are the 
Implications for Drug Policy?
Louisa Degenhardt, Carolyn Day, Wayne Hall, Dave R Bewley-Taylor, July 2007.

Number 13. At a Crossroads: Drug Trafficking, Violence and the Mexican State
Maureen Meyer, with contributions from Coletta Youngers and Dave Bewley-Taylor,
November 2007.

Number 14. The Effects of Decriminalization of Drug Use in Portugal
Caitlin Hughes, Alex Stevens, December 2007.

Number 15. Drug Control in Georgia: Drug Testing and the Reduction of Drug Use
David Otiashvili, Péter Sározi, Gábor L Somogyi, May 2008.

Number 16. Ten Years of Plan Colombia: An Analytic Assessment
Beatriz Acevedo, with Dave Bewley-Taylor and Coletta Youngers, September 2008.

Leave a Comment